SlideShare a Scribd company logo
 Substances that are capable of inducing
.
 They can be recognized by the surface
antibody(B cells) or by the T cell
receptors when associated with MHC
molecule.
 They can with the
antibody or T- cell receptor.
CLASSIFICATION OF ANTIGENS
EXOGENOUS ANTIGENS
Exogenous antigens are those
antigens which enter into the host body from their
surroundings or external environments. These are
basically of pollutants, microorganisms, pollens, drugs
etc.
ENDOGENOUS ANTIGENS
They are again classified onto –
Xeno-genic or Heterogenic antigens
Allogenic or Idiotypic antigens
Autologous antigens.
- Foreign
items which are related with tissue
transplantation and serology.
- Foreign
items which enter when an individual
receives a blood transfusion or undergoes
transplantation operation.
- This
group of antigens is very rare and unnatural.
In normal condition, self-components are
non-immunogenic in nature, but in an
abnormal condition self-body components are
started to be considered as non-self or
antigenic component.
– Ability to induce a
humoral or cell mediated immune
response.
– Ability to combine
specifically with the final products of
humoral or cell mediated immune
response.
 All molecules possessing the
property of immunogenicity also
possess the property of antigenicity.
 Some molecules that possess the
property of antigenicity but lack
immunogenicity is known as
Contribution of the Immunogen
Foreignness
Molecular size
Chemical Composition
Physical Form
Degradability
Contribution of the biological system
Genetic factors
Age
Method of administration
Dose
Route
Adjuvants
1. Foreignness
The immune system normally discriminates between self and
non-self such that only foreign molecules are immunogenic.
When an antigen is introduced into an organism,
2. Molecular Size
There is not absolute size above which a substance will be
immunogenic. However, in general
it is likely to be.
The best immunogens tend to have a molecular mass
approaching 100,000 Da .The poor immunogens generally
have a molecular size b/w 5000 – 10000 Da.
3.Chemical Composition
In general,
. The addition of
aromatic amino acids like tyrosine or phenyalanine to
synthetic polymers can have a profound effect on
immunogenicity. All four levels of protein can contribute to
the antigenic determininant and hence affect the
immunogenicity.
4.Physical form
In general particulate antigens are more
immunogenic than soluble ones and denatured
antigens more immunogenic than the native form.
5. Degradability
Antigens that are
. This is because
for most antigens the development of an immune
response requires that the antigen be
phagocytosed, processed and presented to helper T
cells by an antigen presenting cell (APC).
1. Genetic Factors
 Some substances are immunogenic in one species but not in another.
 Similarly, some substances are immunogenic in one individual but
not in others.
 The species or individuals may lack or have altered genes that
for antigen on B cells and T cells or they may not
have the appropriate genes needed for the APC to present antigen to
the helper cell.
2. Age
 Age can also influence immunogenicity.
 Usually the very young and the very old have a
diminished ability to mount and immune response to an
immunogen.
1. Dose
 The dose of administration of an immunogen can
influence its immunogenicity.
 There is a dose of antigen above or below which the
immune response will not be optimal.
 An insufficient dose will not stimulate an immune
response either because it fails to activate enough
lymphocytes or because it induces a nonresponsive
state.
 An excessively high dose also can fail to induce a
response because it causes lymphocytes to enter a non
responsive state.
2. Route
Intravenous : into a vein
Intradermal : into the skin
Subcutaneous : beneath the skin
Intramuscular : into a muscle
Intraperitoneal : into the peritoneal cavity
 The administration route determines which immune organs and cell
populations will be involved in the response.
 Antigen administrated intravenously is carried first to the spleen, whereas
antigen administrated subcutaneously moves first to local lymph nodes.
3. Adjuvants
 Substances that are mixed
with an antigen and injected
with it, serve to enhance the
immunogenicity of the
antigen.
They are often used to boost
the immune response when
an antigen has low
immunogenicity or when
only small amounts of an
antigen are available, limiting
the immunizing dosage.
 Aluminum potassium sulfate acts to increase antigen
persistence.
 When an antigen is mixed with alum, the salt precipitates
the antigen. Injection of this alum precipitate results in a
slower release of antigen from the injection site, so that the
effective time of exposure to the antigen increases from a
few days without adjuvant to several weeks with the
adjuvant.
 The alum precipitate also increases the size of the antigen,
thus increasing the likelihood of phagocytosis.
Freund’s water-in-oil adjuvants also function to prolong antigen persistence.
FREUND’S INCOMPLETE ADJUVANT
Contains antigen in aqueous solution; mineral oil, and an emulsifing agent such as
mannide monooleate, which disperses the oil into small droplets surrounding the
antigen; the antigen is then released very slowly from the site of injection.
FREUNDS COMPLETE ADJUVANT
Contains heat killed Mycobacteria in the water-in-oil emulsion. In addition, a
muramyl dipeptide component of the myobacterial cell wall activates macrophages.
Activated macrophages are more phagocytic.
• Alum and both Freund’s adjuvants
stimulate a local, chronic inflammatory
response with an increase in phagocytic
cells as well as lymphocytes.
• This cellular inflammatory at the site of
the adjuvant injection often results in
formation of a dense, macrophage rich
mass of cells called a granuloma.
• Because the macrophages in a granuloma
are activated, this mechanism also
enhance TH – cell activation.
• Other adjuvants such as synthetic
polyribonucleotides and bacterial
lipopolysaccharides stimulate nonspecific
lymphocyte proliferation and thus
increase the likelihood of antigen-
induced clonal selection of lymphocytes.
EPITOPES
• An antigen is the part of an antigen that is
recognized by the immune system specifically by
antibodies, B cells or T cells.
• They are also known as epitopes or antigenic
determinants.
• B and T cell recognize different epitopes on the
same antigenic molecule.
• In the case of protein antigens, an epitope may
involve elements of the primary, secondary,
tertiary and even quartenary structure of the
protein.
• In the case of polysaccharide antigens, excessive
side chain branching via glycosidic bonds affects
the overall three dimensional conformation of
individual epitopes.
• T and B cell exhibit fundamental
difference in antigen recognition.
• B cells bind antigen that is free in
solution, the epitopes they recognize
tend to be highly accessible sites on
the exposed surface of the
immunogen.
• T cells only recognize processed
peptides associated with MHC
molecule on the surface of antigen
presenting cell and altered self cells.
MITOGENS
• Mitogens are agents capable of
inducing cell division in a high
percentage of T or B cells.
• A mitogen can activate many clones of
T or B cells irrespective of their antigen
specificity. Hence they are also known
as polyclonal activators.
• Several common mitogens are sugar binding
proteins called lecithins which bind specifically
to different glycoproteins on the surface of
various cells including lymphocytes.
• Binding of lectin molecules to membrane
glycoproteins often leads to agglutination, or
clustering of the cells which may trigger
cellular activation and proliferation.
• Some mitogens preferentially activate B cells,
some preferentially activate T cells and some
activate both populations.
• Three common lectins with mitogenic activity
are concanavalin A, phytohemagglutinin(PHA),
and pokeweed mitogen (PMW).
• The lipopolysaccharide component of the gram
negative bacterial cell wall functions as a B cell
mitogen.
• The mitogenic activity of LPS is due to its lipid
moiety, which is thought to interact with the plasma
membrane, resulting in a cellular activation signal.
Superantigens
 They are the most potent T-cell mitogens known.
 Superantigens bind to residues in the V(variable)
domain of the T-cell receptor and to residues in Class
II MHC molecule outside of the antigen-binding cleft.
 In this way a superantigen can cross-link a T cell to a
Class II MHC molecule even when the TCR does not
recognize the bound antigenic peptide, leading to
activation of the T cell.
 Thus a superantigen can activate all T cells
expressing the V domain to which that superantigen
binds.
 Common superantigens include the staphylococcal
enterotoxins(Ses) and toxic shock syndrome
toxin(TSS1), which is produced by the gram positive
bacterium Staphylococcal aureus.

More Related Content

What's hot

Brief history of immunology
Brief history of immunologyBrief history of immunology
Brief history of immunology
Dhanya K C
 
Humoral immunity
Humoral immunityHumoral immunity
Humoral immunity
Amen Ullah
 
5 immune defense against bacterial pathogens
5 immune defense against bacterial  pathogens5 immune defense against bacterial  pathogens
5 immune defense against bacterial pathogens
Prabesh Raj Jamkatel
 
Antigen processing and presentation
Antigen processing and presentationAntigen processing and presentation
Antigen processing and presentation
Rajpal Choudhary
 
Antigens, Haptens and Adjuvants
Antigens, Haptens and AdjuvantsAntigens, Haptens and Adjuvants
Antigens, Haptens and Adjuvants
Saranraj P
 
antigen antibody interaction
antigen antibody interactionantigen antibody interaction
antigen antibody interaction
Arunima Sur
 
B cell(Immunology)
B cell(Immunology)B cell(Immunology)
B cell(Immunology)
Caroline Karunya
 
Immunogenecity and antigenecity
Immunogenecity and antigenecityImmunogenecity and antigenecity
Immunogenecity and antigenecity
J K COLLEGE,PURULIA
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
PrashantSharma807
 
Antigen & antigenicity
Antigen & antigenicityAntigen & antigenicity
Polyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody productionPolyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody production
Dr. Amer Ali Khaleel /HMU
 
Antibodies
AntibodiesAntibodies
Antibodies
SHRUTHI VASAN
 
Adaptive immunity
Adaptive immunityAdaptive immunity
Adaptive immunity
Hari Sharan Makaju
 
Immunologic memory
Immunologic memoryImmunologic memory
Immunologic memory
Dr. Ashish Warghane, Ph.D
 
Cells & organs ofthe immune system
Cells & organs ofthe immune systemCells & organs ofthe immune system
Cells & organs ofthe immune systemBruno Mmassy
 
Immunologic tolerance
Immunologic toleranceImmunologic tolerance
Immunologic toleranceRobin Gulati
 
Organs of the immune system
Organs of the immune systemOrgans of the immune system
Organs of the immune system
National Academy of Young Scientists
 
Antigen
AntigenAntigen
T-cell
T-cellT-cell
Introduction to antigen
Introduction to  antigenIntroduction to  antigen
Introduction to antigen
Amjad Afridi
 

What's hot (20)

Brief history of immunology
Brief history of immunologyBrief history of immunology
Brief history of immunology
 
Humoral immunity
Humoral immunityHumoral immunity
Humoral immunity
 
5 immune defense against bacterial pathogens
5 immune defense against bacterial  pathogens5 immune defense against bacterial  pathogens
5 immune defense against bacterial pathogens
 
Antigen processing and presentation
Antigen processing and presentationAntigen processing and presentation
Antigen processing and presentation
 
Antigens, Haptens and Adjuvants
Antigens, Haptens and AdjuvantsAntigens, Haptens and Adjuvants
Antigens, Haptens and Adjuvants
 
antigen antibody interaction
antigen antibody interactionantigen antibody interaction
antigen antibody interaction
 
B cell(Immunology)
B cell(Immunology)B cell(Immunology)
B cell(Immunology)
 
Immunogenecity and antigenecity
Immunogenecity and antigenecityImmunogenecity and antigenecity
Immunogenecity and antigenecity
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Antigen & antigenicity
Antigen & antigenicityAntigen & antigenicity
Antigen & antigenicity
 
Polyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody productionPolyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody production
 
Antibodies
AntibodiesAntibodies
Antibodies
 
Adaptive immunity
Adaptive immunityAdaptive immunity
Adaptive immunity
 
Immunologic memory
Immunologic memoryImmunologic memory
Immunologic memory
 
Cells & organs ofthe immune system
Cells & organs ofthe immune systemCells & organs ofthe immune system
Cells & organs ofthe immune system
 
Immunologic tolerance
Immunologic toleranceImmunologic tolerance
Immunologic tolerance
 
Organs of the immune system
Organs of the immune systemOrgans of the immune system
Organs of the immune system
 
Antigen
AntigenAntigen
Antigen
 
T-cell
T-cellT-cell
T-cell
 
Introduction to antigen
Introduction to  antigenIntroduction to  antigen
Introduction to antigen
 

Viewers also liked

Antigen
AntigenAntigen
Antigen
Natasha Sayal
 
Antigens, hapteins, immunogens lectures 10.1.06
Antigens, hapteins, immunogens lectures 10.1.06Antigens, hapteins, immunogens lectures 10.1.06
Antigens, hapteins, immunogens lectures 10.1.06Bruno Mmassy
 
Superantigen
SuperantigenSuperantigen
Superantigen
Ruchi
 

Viewers also liked (6)

Superantigen
SuperantigenSuperantigen
Superantigen
 
Antigen
AntigenAntigen
Antigen
 
Antigens, hapteins, immunogens lectures 10.1.06
Antigens, hapteins, immunogens lectures 10.1.06Antigens, hapteins, immunogens lectures 10.1.06
Antigens, hapteins, immunogens lectures 10.1.06
 
Superantigen
SuperantigenSuperantigen
Superantigen
 
Antigen
AntigenAntigen
Antigen
 
Antigens
AntigensAntigens
Antigens
 

Similar to Antigens

ANTIGENS of immune system & VACCINES .pptx
ANTIGENS of immune system & VACCINES .pptxANTIGENS of immune system & VACCINES .pptx
ANTIGENS of immune system & VACCINES .pptx
drshrutkirtigupta
 
Antigens and conepts of vaccine
Antigens and conepts of vaccineAntigens and conepts of vaccine
Antigens and conepts of vaccine
shivaakumar
 
Immunogens and antigens
Immunogens and antigensImmunogens and antigens
Immunogens and antigens
Jyotipnigam
 
Nature of antigens
Nature of antigensNature of antigens
Nature of antigensYeyeh Santos
 
Antigens ms
Antigens msAntigens ms
Multi Drug Resistence Bacteria.pptx
Multi Drug Resistence Bacteria.pptxMulti Drug Resistence Bacteria.pptx
Multi Drug Resistence Bacteria.pptx
BIOGENLABS
 
Antigen.pptx
Antigen.pptxAntigen.pptx
Antigen.pptx
Neeraj Ojha
 
Antigen lecture-51 (1)
Antigen lecture-51 (1)Antigen lecture-51 (1)
Antigen lecture-51 (1)
Naeem Ahmed
 
Antigens notes
Antigens notes Antigens notes
Antigens notes
Vamsi kumar
 
...Serological Technique Presentation Group 8 th.pptx
...Serological Technique Presentation Group 8 th.pptx...Serological Technique Presentation Group 8 th.pptx
...Serological Technique Presentation Group 8 th.pptx
BIOGENLABS
 
Group no 6 immunology
Group no 6 immunologyGroup no 6 immunology
Group no 6 immunologyPeter Massawe
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).ppt
nedalalazzwy
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).ppt
nedalalazzwy
 
Lingga Adaptive Imun.pptx
Lingga Adaptive Imun.pptxLingga Adaptive Imun.pptx
Lingga Adaptive Imun.pptx
UswatunAortatikaKhas
 
Immunochemistry by dr.reena
Immunochemistry by dr.reenaImmunochemistry by dr.reena
Immunochemistry by dr.reena
Dr.reena singh
 
(5) the classification and the significance of the Antigenic molecules.pptx
(5) the classification and the significance of the Antigenic molecules.pptx(5) the classification and the significance of the Antigenic molecules.pptx
(5) the classification and the significance of the Antigenic molecules.pptx
AmirRaziq1
 
IMMUNOMODULATORS :- Mode and mechanism of their action
IMMUNOMODULATORS :- Mode and mechanism of their actionIMMUNOMODULATORS :- Mode and mechanism of their action
IMMUNOMODULATORS :- Mode and mechanism of their action
SUMIT KOLTE
 
T cell stimulation by drugs
T cell stimulation by drugsT cell stimulation by drugs
T cell stimulation by drugs
Domina Petric
 
1. immunity 2017 (1).pptx
1. immunity 2017 (1).pptx1. immunity 2017 (1).pptx
1. immunity 2017 (1).pptx
M Chaudhary
 
L3.0 Antigen,Hapten and Immunogen.pptx
L3.0 Antigen,Hapten and Immunogen.pptxL3.0 Antigen,Hapten and Immunogen.pptx
L3.0 Antigen,Hapten and Immunogen.pptx
Vickshayo Sss
 

Similar to Antigens (20)

ANTIGENS of immune system & VACCINES .pptx
ANTIGENS of immune system & VACCINES .pptxANTIGENS of immune system & VACCINES .pptx
ANTIGENS of immune system & VACCINES .pptx
 
Antigens and conepts of vaccine
Antigens and conepts of vaccineAntigens and conepts of vaccine
Antigens and conepts of vaccine
 
Immunogens and antigens
Immunogens and antigensImmunogens and antigens
Immunogens and antigens
 
Nature of antigens
Nature of antigensNature of antigens
Nature of antigens
 
Antigens ms
Antigens msAntigens ms
Antigens ms
 
Multi Drug Resistence Bacteria.pptx
Multi Drug Resistence Bacteria.pptxMulti Drug Resistence Bacteria.pptx
Multi Drug Resistence Bacteria.pptx
 
Antigen.pptx
Antigen.pptxAntigen.pptx
Antigen.pptx
 
Antigen lecture-51 (1)
Antigen lecture-51 (1)Antigen lecture-51 (1)
Antigen lecture-51 (1)
 
Antigens notes
Antigens notes Antigens notes
Antigens notes
 
...Serological Technique Presentation Group 8 th.pptx
...Serological Technique Presentation Group 8 th.pptx...Serological Technique Presentation Group 8 th.pptx
...Serological Technique Presentation Group 8 th.pptx
 
Group no 6 immunology
Group no 6 immunologyGroup no 6 immunology
Group no 6 immunology
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).ppt
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).ppt
 
Lingga Adaptive Imun.pptx
Lingga Adaptive Imun.pptxLingga Adaptive Imun.pptx
Lingga Adaptive Imun.pptx
 
Immunochemistry by dr.reena
Immunochemistry by dr.reenaImmunochemistry by dr.reena
Immunochemistry by dr.reena
 
(5) the classification and the significance of the Antigenic molecules.pptx
(5) the classification and the significance of the Antigenic molecules.pptx(5) the classification and the significance of the Antigenic molecules.pptx
(5) the classification and the significance of the Antigenic molecules.pptx
 
IMMUNOMODULATORS :- Mode and mechanism of their action
IMMUNOMODULATORS :- Mode and mechanism of their actionIMMUNOMODULATORS :- Mode and mechanism of their action
IMMUNOMODULATORS :- Mode and mechanism of their action
 
T cell stimulation by drugs
T cell stimulation by drugsT cell stimulation by drugs
T cell stimulation by drugs
 
1. immunity 2017 (1).pptx
1. immunity 2017 (1).pptx1. immunity 2017 (1).pptx
1. immunity 2017 (1).pptx
 
L3.0 Antigen,Hapten and Immunogen.pptx
L3.0 Antigen,Hapten and Immunogen.pptxL3.0 Antigen,Hapten and Immunogen.pptx
L3.0 Antigen,Hapten and Immunogen.pptx
 

More from devadevi666

Leukocyte extravasation
Leukocyte extravasationLeukocyte extravasation
Leukocyte extravasation
devadevi666
 
Genetic counselling
Genetic counsellingGenetic counselling
Genetic counselling
devadevi666
 
Regulation of lactogenic hormones
Regulation of lactogenic hormonesRegulation of lactogenic hormones
Regulation of lactogenic hormones
devadevi666
 
Celiac Disease - Sprue, Nontropica sprue
Celiac Disease - Sprue, Nontropica sprueCeliac Disease - Sprue, Nontropica sprue
Celiac Disease - Sprue, Nontropica sprue
devadevi666
 
Cholesterol biosynthesis
Cholesterol biosynthesisCholesterol biosynthesis
Cholesterol biosynthesis
devadevi666
 
Oxidative phosphorylation
Oxidative phosphorylationOxidative phosphorylation
Oxidative phosphorylation
devadevi666
 
Tryptophan operon
Tryptophan operonTryptophan operon
Tryptophan operon
devadevi666
 
Antimetabolites and suicide inhibitors
Antimetabolites and suicide inhibitorsAntimetabolites and suicide inhibitors
Antimetabolites and suicide inhibitors
devadevi666
 
PROTEIN STRUCTURE PRESENTATION
PROTEIN STRUCTURE PRESENTATIONPROTEIN STRUCTURE PRESENTATION
PROTEIN STRUCTURE PRESENTATION
devadevi666
 
Colloids presentation slides
Colloids presentation slidesColloids presentation slides
Colloids presentation slides
devadevi666
 
Mitochondria ppt
Mitochondria pptMitochondria ppt
Mitochondria ppt
devadevi666
 

More from devadevi666 (11)

Leukocyte extravasation
Leukocyte extravasationLeukocyte extravasation
Leukocyte extravasation
 
Genetic counselling
Genetic counsellingGenetic counselling
Genetic counselling
 
Regulation of lactogenic hormones
Regulation of lactogenic hormonesRegulation of lactogenic hormones
Regulation of lactogenic hormones
 
Celiac Disease - Sprue, Nontropica sprue
Celiac Disease - Sprue, Nontropica sprueCeliac Disease - Sprue, Nontropica sprue
Celiac Disease - Sprue, Nontropica sprue
 
Cholesterol biosynthesis
Cholesterol biosynthesisCholesterol biosynthesis
Cholesterol biosynthesis
 
Oxidative phosphorylation
Oxidative phosphorylationOxidative phosphorylation
Oxidative phosphorylation
 
Tryptophan operon
Tryptophan operonTryptophan operon
Tryptophan operon
 
Antimetabolites and suicide inhibitors
Antimetabolites and suicide inhibitorsAntimetabolites and suicide inhibitors
Antimetabolites and suicide inhibitors
 
PROTEIN STRUCTURE PRESENTATION
PROTEIN STRUCTURE PRESENTATIONPROTEIN STRUCTURE PRESENTATION
PROTEIN STRUCTURE PRESENTATION
 
Colloids presentation slides
Colloids presentation slidesColloids presentation slides
Colloids presentation slides
 
Mitochondria ppt
Mitochondria pptMitochondria ppt
Mitochondria ppt
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 

Antigens

  • 1.
  • 2.  Substances that are capable of inducing .  They can be recognized by the surface antibody(B cells) or by the T cell receptors when associated with MHC molecule.  They can with the antibody or T- cell receptor.
  • 3. CLASSIFICATION OF ANTIGENS EXOGENOUS ANTIGENS Exogenous antigens are those antigens which enter into the host body from their surroundings or external environments. These are basically of pollutants, microorganisms, pollens, drugs etc. ENDOGENOUS ANTIGENS They are again classified onto – Xeno-genic or Heterogenic antigens Allogenic or Idiotypic antigens Autologous antigens.
  • 4. - Foreign items which are related with tissue transplantation and serology. - Foreign items which enter when an individual receives a blood transfusion or undergoes transplantation operation. - This group of antigens is very rare and unnatural. In normal condition, self-components are non-immunogenic in nature, but in an abnormal condition self-body components are started to be considered as non-self or antigenic component.
  • 5. – Ability to induce a humoral or cell mediated immune response. – Ability to combine specifically with the final products of humoral or cell mediated immune response.  All molecules possessing the property of immunogenicity also possess the property of antigenicity.  Some molecules that possess the property of antigenicity but lack immunogenicity is known as
  • 6. Contribution of the Immunogen Foreignness Molecular size Chemical Composition Physical Form Degradability Contribution of the biological system Genetic factors Age Method of administration Dose Route Adjuvants
  • 7. 1. Foreignness The immune system normally discriminates between self and non-self such that only foreign molecules are immunogenic. When an antigen is introduced into an organism, 2. Molecular Size There is not absolute size above which a substance will be immunogenic. However, in general it is likely to be. The best immunogens tend to have a molecular mass approaching 100,000 Da .The poor immunogens generally have a molecular size b/w 5000 – 10000 Da.
  • 8.
  • 9. 3.Chemical Composition In general, . The addition of aromatic amino acids like tyrosine or phenyalanine to synthetic polymers can have a profound effect on immunogenicity. All four levels of protein can contribute to the antigenic determininant and hence affect the immunogenicity. 4.Physical form In general particulate antigens are more immunogenic than soluble ones and denatured antigens more immunogenic than the native form.
  • 10. 5. Degradability Antigens that are . This is because for most antigens the development of an immune response requires that the antigen be phagocytosed, processed and presented to helper T cells by an antigen presenting cell (APC).
  • 11. 1. Genetic Factors  Some substances are immunogenic in one species but not in another.  Similarly, some substances are immunogenic in one individual but not in others.  The species or individuals may lack or have altered genes that for antigen on B cells and T cells or they may not have the appropriate genes needed for the APC to present antigen to the helper cell.
  • 12. 2. Age  Age can also influence immunogenicity.  Usually the very young and the very old have a diminished ability to mount and immune response to an immunogen.
  • 13. 1. Dose  The dose of administration of an immunogen can influence its immunogenicity.  There is a dose of antigen above or below which the immune response will not be optimal.  An insufficient dose will not stimulate an immune response either because it fails to activate enough lymphocytes or because it induces a nonresponsive state.  An excessively high dose also can fail to induce a response because it causes lymphocytes to enter a non responsive state.
  • 14. 2. Route Intravenous : into a vein Intradermal : into the skin Subcutaneous : beneath the skin Intramuscular : into a muscle Intraperitoneal : into the peritoneal cavity  The administration route determines which immune organs and cell populations will be involved in the response.  Antigen administrated intravenously is carried first to the spleen, whereas antigen administrated subcutaneously moves first to local lymph nodes.
  • 15. 3. Adjuvants  Substances that are mixed with an antigen and injected with it, serve to enhance the immunogenicity of the antigen. They are often used to boost the immune response when an antigen has low immunogenicity or when only small amounts of an antigen are available, limiting the immunizing dosage.
  • 16.  Aluminum potassium sulfate acts to increase antigen persistence.  When an antigen is mixed with alum, the salt precipitates the antigen. Injection of this alum precipitate results in a slower release of antigen from the injection site, so that the effective time of exposure to the antigen increases from a few days without adjuvant to several weeks with the adjuvant.  The alum precipitate also increases the size of the antigen, thus increasing the likelihood of phagocytosis.
  • 17. Freund’s water-in-oil adjuvants also function to prolong antigen persistence. FREUND’S INCOMPLETE ADJUVANT Contains antigen in aqueous solution; mineral oil, and an emulsifing agent such as mannide monooleate, which disperses the oil into small droplets surrounding the antigen; the antigen is then released very slowly from the site of injection. FREUNDS COMPLETE ADJUVANT Contains heat killed Mycobacteria in the water-in-oil emulsion. In addition, a muramyl dipeptide component of the myobacterial cell wall activates macrophages. Activated macrophages are more phagocytic.
  • 18. • Alum and both Freund’s adjuvants stimulate a local, chronic inflammatory response with an increase in phagocytic cells as well as lymphocytes. • This cellular inflammatory at the site of the adjuvant injection often results in formation of a dense, macrophage rich mass of cells called a granuloma. • Because the macrophages in a granuloma are activated, this mechanism also enhance TH – cell activation. • Other adjuvants such as synthetic polyribonucleotides and bacterial lipopolysaccharides stimulate nonspecific lymphocyte proliferation and thus increase the likelihood of antigen- induced clonal selection of lymphocytes.
  • 19. EPITOPES • An antigen is the part of an antigen that is recognized by the immune system specifically by antibodies, B cells or T cells. • They are also known as epitopes or antigenic determinants. • B and T cell recognize different epitopes on the same antigenic molecule. • In the case of protein antigens, an epitope may involve elements of the primary, secondary, tertiary and even quartenary structure of the protein. • In the case of polysaccharide antigens, excessive side chain branching via glycosidic bonds affects the overall three dimensional conformation of individual epitopes.
  • 20. • T and B cell exhibit fundamental difference in antigen recognition. • B cells bind antigen that is free in solution, the epitopes they recognize tend to be highly accessible sites on the exposed surface of the immunogen. • T cells only recognize processed peptides associated with MHC molecule on the surface of antigen presenting cell and altered self cells.
  • 21. MITOGENS • Mitogens are agents capable of inducing cell division in a high percentage of T or B cells. • A mitogen can activate many clones of T or B cells irrespective of their antigen specificity. Hence they are also known as polyclonal activators.
  • 22. • Several common mitogens are sugar binding proteins called lecithins which bind specifically to different glycoproteins on the surface of various cells including lymphocytes. • Binding of lectin molecules to membrane glycoproteins often leads to agglutination, or clustering of the cells which may trigger cellular activation and proliferation. • Some mitogens preferentially activate B cells, some preferentially activate T cells and some activate both populations. • Three common lectins with mitogenic activity are concanavalin A, phytohemagglutinin(PHA), and pokeweed mitogen (PMW).
  • 23. • The lipopolysaccharide component of the gram negative bacterial cell wall functions as a B cell mitogen. • The mitogenic activity of LPS is due to its lipid moiety, which is thought to interact with the plasma membrane, resulting in a cellular activation signal.
  • 24. Superantigens  They are the most potent T-cell mitogens known.  Superantigens bind to residues in the V(variable) domain of the T-cell receptor and to residues in Class II MHC molecule outside of the antigen-binding cleft.  In this way a superantigen can cross-link a T cell to a Class II MHC molecule even when the TCR does not recognize the bound antigenic peptide, leading to activation of the T cell.  Thus a superantigen can activate all T cells expressing the V domain to which that superantigen binds.  Common superantigens include the staphylococcal enterotoxins(Ses) and toxic shock syndrome toxin(TSS1), which is produced by the gram positive bacterium Staphylococcal aureus.